Reza Wakili
Overview
Explore the profile of Reza Wakili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schlender L, Ochs M, Wakili R, Stohr R, Emrich F, Walther T, et al.
Circ Heart Fail
. 2025 Feb;
:e011639.
PMID: 39981571
No abstract available.
2.
Johnson V, Antepara C, Wakili R, Schmitt J
Herzschrittmacherther Elektrophysiol
. 2025 Feb;
36(1):21-27.
PMID: 39966147
The cornerstone of heart failure treatment consists of a four pillar drug therapy. Patients with existing heart failure and complete left bundle branch block, or patients with an indication for...
3.
Isaacs A, Zeemering S, Winters J, Batlle M, Bidar E, Boukens B, et al.
Circ Genom Precis Med
. 2025 Jan;
18(1):e004594.
PMID: 39846178
Background: Transcriptional dysregulation, possibly affected by genetic variation, contributes to disease etiology. Due to dissimilarities in development, function, and remodeling during disease progression, transcriptional differences between the left atrium (LA)...
4.
Scherr D, Turagam M, Maury P, Blaauw Y, van der Voort P, Neuzil P, et al.
Europace
. 2025 Jan;
PMID: 39824172
Background: Initial clinical studies of pulsed field ablation (PFA) to treat atrial fibrillation (AF) indicated a >90% durability rate of pulmonary vein isolation (PVI). However, these studies were largely conducted...
5.
Peichl P, Bayes-Genis A, Deneke T, Chioncel O, deRiva M, Crespo-Leiro M, et al.
Europace
. 2024 Oct;
26(11).
PMID: 39478667
Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure. Although these devices effectively improve survival, atrial and ventricular arrhythmias are...
6.
Ekanem E, Neuzil P, Reichlin T, Kautzner J, van der Voort P, Jais P, et al.
Nat Med
. 2024 Jul;
30(7):2020-2029.
PMID: 38977913
Pulsed field ablation (PFA) is an emerging technology for the treatment of atrial fibrillation (AF), for which pre-clinical and early-stage clinical data are suggestive of some degree of preferentiality to...
7.
Rudolph I, Mastella G, Bernlochner I, Steger A, von Olshausen G, Hahn F, et al.
Eur Heart J Open
. 2024 Jun;
4(3):oeae044.
PMID: 38933428
Aims: Pulmonary vein isolation (PVI) represents the gold standard in the treatment of atrial fibrillation (AF) and the use of single-shot techniques, such as cryoballoon ablation (CBA) and pulsed field...
8.
Turagam M, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A, et al.
JACC Clin Electrophysiol
. 2024 Jun;
PMID: 38869506
Background: Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF). Objective:...
9.
Turagam M, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A, et al.
JACC Clin Electrophysiol
. 2024 Jun;
PMID: 38864809
Background: Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF). Objective:...
10.
Barkauskas R, Jenewein T, Scheiper-Welling S, Wilmes V, Niess C, Petzel-Witt S, et al.
Clin Res Cardiol
. 2024 May;
PMID: 38748206
Background: Approximately one-third of sudden cardiac deaths in the young (SCDY) occur due to a structural cardiac disease. Forty to fifty percent of SCDY cases remain unexplained after autopsy (including...